One-year results from a study of Smith & Nephew's NOVOSTITCH™ Meniscal Repair System demonstrated a success rate of 91.7% (reoperation rate of 8.3%), and significant improvement in knee pain and function in all patient reported outcomes including Knee injury and Osteoarthritis Outcome Score (KOOS), International Knee Documentation Committee (IKDC), Lysholm and Tegner scores.
The STITCH Study is a prospective clinical trial examining effectiveness in the repair of Horizontal Cleavage Tears. The trial enrolled 30 patients with meniscal tears at eight U.S. sites. STITCH will continue to follow patients for two years post-op.
STITCH Study Principal Investigator and orthopedic surgeon, Dr. Peter Kurzweil, said, "The one-year results from STITCH are compelling, as the data challenges the notion that HCTs have an unacceptably low rate of repair success when in fact, they have comparable success rates to those of other meniscal tears."
Source: Smith & Nephew